These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23490041)

  • 21. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention with stenting.
    Bae JH; Bassenge E; Kim KY; Synn YC; Park KR; Schwemmer M
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):185-92. PubMed ID: 15378139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin.
    Piorkowski M; Weikert U; Schwimmbeck PL; Martus P; Schultheiss HP; Rauch U
    Thromb Haemost; 2004 Sep; 92(3):614-20. PubMed ID: 15351859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome.
    Hong SJ; Park JY; Kim KA; Ahn CM; Park JS; Kim YH; Shim WJ; Park SM; Lim DS
    Circ J; 2009 Jun; 73(6):1111-8. PubMed ID: 19372620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4.
    Polena S; Gupta MP; Shaikh H; Zazzali K; Coplan N; Gintautas J; Labana SS; Soffer D
    Proc West Pharmacol Soc; 2008; 51():60-2. PubMed ID: 19544679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
    Sorkin GC; Dumont TM; Wach MM; Eller JL; Mokin M; Natarajan SK; Baxter MS; Snyder KV; Levy EI; Hopkins LN; Siddiqui AH
    J Neurointerv Surg; 2014 Jun; 6(5):373-8. PubMed ID: 23794673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Secondary prevention after ischemic stroke].
    Baumgartner RW; Georgiadis D
    Praxis (Bern 1994); 2003 Jan; 92(5):168-78. PubMed ID: 12643070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
    Nakagawa I; Park HS; Wada T; Yokoyama S; Yamada S; Motoyama Y; Kichikawa K; Nakase H
    Neurol Res; 2017 Aug; 39(8):695-701. PubMed ID: 28290236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose effect of clopidogrel reloading in patients already on 75-mg maintenance dose: the Reload with Clopidogrel Before Coronary Angioplasty in Subjects Treated Long Term with Dual Antiplatelet Therapy (RELOAD) study.
    Collet JP; Silvain J; Landivier A; Tanguy ML; Cayla G; Bellemain A; Vignolles N; Gallier S; Beygui F; Pena A; Montalescot G
    Circulation; 2008 Sep; 118(12):1225-33. PubMed ID: 18765393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial.
    Saw J; Brennan DM; Steinhubl SR; Bhatt DL; Mak KH; Fox K; Topol EJ;
    J Am Coll Cardiol; 2007 Jul; 50(4):291-5. PubMed ID: 17659194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation).
    Poyet R; Cuisset T; Frere C; Quilici J; Gaborit B; Moro PJ; Camoin L; Morange PE; Bonnet JL; Alessi MC
    Thromb Res; 2010 Nov; 126(5):e397-9. PubMed ID: 20825983
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects.
    Farid NA; Small DS; Payne CD; Jakubowski JA; Brandt JT; Li YG; Ernest CS; Salazar DE; Konkoy CS; Winters KJ
    Pharmacotherapy; 2008 Dec; 28(12):1483-94. PubMed ID: 19025429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting].
    Han YL; Li CY; Li Y; Kang J; Yan CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):788-92. PubMed ID: 18070466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
    Van Der Heyden J; Van Werkum J; Hackeng CM; Kelder JC; Breet NJ; Deneer VH; Ackerstaff RG; Tromp SC; De Vries JP; Vos JA; Suttorp MJ; Elsenberg EH; Van Neerven D; Schonewille WJ; Wolters F; Ten Berg JM
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):337-47. PubMed ID: 23138609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
    Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
    Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
    Smith SM; Judge HM; Peters G; Storey RF
    Platelets; 2004 Dec; 15(8):465-74. PubMed ID: 15763887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.